How to Take CJC-1295 DAC: Dosing, Timing, and Safety

CJC-1295 DAC is generally administered as a subcutaneous injection, most often at 1–2 mg per week, because its Drug Affinity Complex binds albumin and stretches its half-life to roughly six to eight days. That long half-life means injection timing matters far less than it does with short-acting growth hormone secretagogues. CJC-1295 DAC is not FDA-approved for human use in the United States and is sold only as a research chemical, so the details below describe published research and common laboratory practice rather than a clinical treatment plan.

What CJC-1295 DAC Is and How It Differs

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). The "DAC" portion is a maleimide group that covalently binds the peptide to albumin in the bloodstream, which is what keeps it circulating for days instead of minutes.

That binding is the main thing separating it from the original compound:

Feature	CJC-1295 DAC	CJC-1295 without DAC (Mod GRF 1-29)
Half-life	About 6–8 days	About 30 minutes
Typical frequency	1–2 times weekly	2–3 times daily
Timing sensitivity	Low	High
Typical research dose	1–2 mg per week	About 100 mcg per injection

Because the DAC version stays active for days, one injection produces a sustained rise in growth hormone and IGF-1 instead of a brief pulse. That is the core trade-off: convenience and steady exposure versus a natural pulsatile pattern.

Typical Research Dosing for CJC-1295 DAC

Published pharmacokinetic studies in healthy adults used single subcutaneous doses of 30 or 60 mcg/kg, and those doses kept IGF-1 elevated for up to six days. Informal protocols that circulate online usually land higher, at 1–2 mg per week.

Protocol	Weekly total	Notes
1 mg twice weekly	2 mg	Lower peaks, steadier exposure
2 mg once weekly	2 mg	Most commonly cited informal protocol
30–60 mcg/kg, single dose	Variable	Dose used in published research

A common vial size is cjc 1295 dac 5mg, which supplies roughly two to five weeks of material depending on how it is dosed. Any vial should list peptide mass, purity percentage, and a batch or lot number.

How to Reconstitute and Inject CJC-1295 DAC

Freeze-dried peptide has to be dissolved before use. Learning how to reconstitute cjc 1295 correctly protects both the peptide itself and the accuracy of your measurements.

1. Clean the work surface and wash your hands.
2. Swab the rubber stopper on the peptide vial and the bacteriostatic water vial with alcohol.
3. Draw the desired volume of bacteriostatic water into a syringe.
4. Insert the needle and let the water run slowly down the inside wall of the vial instead of directly onto the powder.
5. Swirl gently until fully dissolved; never shake, since foaming and shear can damage the peptide.
6. Label the vial with the date and final concentration, then refrigerate at 2–8°C.

If you add 2 mL of water to a 5 mg vial, the concentration is 2.5 mg/mL (2,500 mcg/mL), so a 1 mg dose equals 0.4 mL. Subcutaneous injections are usually placed in the abdomen, outer thigh, or upper arm, with sites rotated to limit irritation.

Timing and Injection Frequency

Because CJC-1295 DAC stays active for about a week, it can be injected at any consistent time of day. There is no strong pharmacological reason to chase a specific clock hour the way you would with a short-acting peptide.

Many people researching blends ask when to inject cjc 1295 ipamorelin, and the answer there is different: ipamorelin clears within minutes, so it is normally dosed shortly before sleep to line up with the body's natural overnight growth hormone pulse.

Fixing one or two weekly injection days and keeping them steady is the simplest approach. Splitting the weekly total into two smaller doses tends to smooth the peak-and-trough curve.

How Long to Run It and Safety Considerations

Researchers asking how long can you take cjc 1295/ipamorelin will find no established human answer, because controlled long-term data do not exist. Informal protocols often run 8–16 weeks followed by a break, but that schedule reflects community habit rather than clinical evidence.

Reported effects in research settings include injection-site irritation, flushing, headache, and mild water retention. Growth hormone and IGF-1 elevation can also influence blood sugar and joint comfort.

• CJC-1295 DAC is not approved by the FDA for human use.
• People with active cancer, uncontrolled diabetes, or pituitary disorders should avoid growth hormone secretagogues.
• WADA and most athletic governing bodies classify CJC-1295 DAC as a banned substance.
• Anyone using a growth hormone secretagogue under medical supervision should have IGF-1 and glucose monitored.

Anyone weighing this peptide should speak with a licensed healthcare professional instead of relying on forum dosing charts.

Legal Status and Sourcing

In the United States, CJC-1295 DAC is sold as a research chemical rather than a prescription or over-the-counter drug. Vendors typically label it "for research use only," and no approved human formulation exists.

People researching how to get cjc-1295 ipamorelin should understand that legality and product quality vary widely between suppliers. Third-party certificates of analysis, mass spectrometry reports, and independent purity testing are the minimum standard for evaluating any vendor.

COMMON QUESTIONS

Frequently Asked Questions

How often do you inject CJC-1295 DAC?

CJC-1295 DAC has a half-life of roughly six to eight days, so it is typically injected once or twice per week in research and informal protocols. Daily dosing is unnecessary because the peptide remains active for days after a single injection. Published studies used single 30–60 mcg/kg doses that kept IGF-1 elevated for up to six days.

Does CJC-1295 DAC need to be refrigerated?

Before reconstitution, the lyophilized powder should be stored in a freezer for long-term stability. After mixing with bacteriostatic water, keep the vial at 2–8°C, protect it from light, and avoid repeated freeze-thaw cycles. A reconstituted vial is generally used within a few weeks.

Is CJC-1295 DAC FDA approved?

CJC-1295 DAC is not FDA-approved for human use in the United States. It is legally sold only as a research chemical and is not available as a prescription medication. Any product marketed for human consumption is being sold outside its approved labeling.